Glia
Closed portfolio with an early-phase archive tilt
According to ClinicalTrials.gov-derived indexes, Glia sits in the upper quartile of US sponsors by registered trial count (#3,661 of 15,742 sponsors by registered trial count).
Glia: 3 sponsored US clinical trials, none currently recruiting.
Glia sponsors 3 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 3 completed. 0 of these trials are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Contact Lens-induced Corneal Fluorescein Staining, with 1 trials.
Upper-quartile sponsor footprint
Glia sits in the upper quartile of the sponsor corpus (#3,661 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Indexed trials (enrollment closed)
3 total, page 1 of 1
Treatment Safety and Efficacy of Pro-ocular™ 1% for Chronic Ocular Graft Following Allogeneic HSCT.
NCT03990051
Prolongation of Contact Lens Comfortable Wear Duration by CLM2 Topical Gel
NCT03994406
Amelioration of Adverse Ocular Side Effects of Glaucoma Medications in Glaucoma Patients Using Topical GL101
NCT02656394
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 3 |
How the Glia early-phase archive is shaped
3 indexed studies, none listed as recruiting (0% open); 3 completed (100%).
Phase mix: 0 late (III/IV) vs 3 early (I/II) (early-phase heavy).
Top condition: Contact Lens-induced Corneal Fluorescein Staining (1 trial), 4 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
Glia: archived-pipeline peers nationwide
Peers matched on 3 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
Glia sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 3 archived trials
- 10xBio · 3 trials · 0% recruiting
- 22nd Century Group · 3 trials · 0% recruiting
- AA Secord · 3 trials · 0% recruiting
- AAADRS Clinical Research Center · 3 trials · 0% recruiting
Sponsors with similar archive density (± trial count)
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
- 3 Waves Wellness · 0% recruiting · 2 trials
- 3EO Health · 0% recruiting · 2 trials
Related
What to do with this Glia page
3 registered trials is a research-attention snapshot, not an endorsement of Glia or any single study.
- None of Glia's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Contact Lens-induced Corneal Fluorescein Staining is the condition Glia studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Contact Lens-induced Corneal Fluorescein Staining trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Glia pipeline card: 3 registered trials from official public datasets.Report a data error.